LY 2245461Alternative Names: LY2245461
Latest Information Update: 29 Mar 2012
At a glance
- Originator Eli Lilly
- Developer Chorus Group
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hot flashes
Most Recent Events
- 28 Mar 2012 Discontinued - Phase-II for Hot flashes in Denmark (unspecified route)
- 21 Jul 2008 Chorus Group completes a phase II trial in Hot flashes in Denmark
- 21 Apr 2008 Phase-II clinical trials in Hot flashes in Denmark (unspecified route)